Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.6750
+0.0100 (1.50%)
Aug 27, 2026, 2:47 PM HKT

HKG:3737 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6471,7372,2152,0501,8261,747
Revenue Growth
-5.21%-21.55%8.05%12.26%4.55%8.89%
Gross Profit
875.92940.251,2811,2151,0671,061
Operating Income
10.88-1.67125.14164.4103.5179.58
Net Income
17.6217.2995.21162.78106.3952.13
Earnings Per Share
0.020.020.110.190.130.06
EPS Growth
5.19%-81.82%-42.11%51.27%109.34%-64.10%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operation of Chain Pharmacies
528.81590.49634.15696.03693.22
Elimination of Intersegment Sales
-592.07-708.24-696.22-717.95-823.96
Pharmaceutical Manufacturing
1,8012,3332,1121,8481,877
Total
1,7372,2152,0501,8261,747

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
161.56198.92199.69192.3419.36257.85
Total Debt
87.63130.01188.6174.86170.86175.74
Net Cash (Debt)
73.9368.9111.0917.45248.582.1
Net Cash Growth
7.29%521.45%-36.45%-92.98%202.67%-33.32%
Net Cash Per Share
0.090.080.010.020.290.10

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-179.7181.48101.5284.57178.38
Capital Expenditures
--35.22-140.76-169.18-88.41-185.85
Free Cash Flow
-144.4740.72-67.68196.17-7.47
Free Cash Flow Growth
-254.76%----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.18%54.12%57.85%59.25%58.45%60.77%
Operating Margin
0.66%-0.10%5.65%8.02%5.67%4.56%
Pretax Margin
1.94%1.09%6.63%10.13%7.16%3.54%
Profit Margin
1.07%1.00%4.30%7.94%5.83%2.99%
FCF Margin
-8.31%1.84%-3.30%10.74%-0.43%

Dividends

Fiscal YearFY 2024FY 2023FY 2022
Period EndingDec '24 Dec '23 Dec '22
Dividend Per Share
0.0470.0820.053
Dividend Per Share Growth
-42.49%53.92%-
Dividend Yield
5.35%6.90%6.80%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
27.3825.148.446.847.8313.36
Forward PE
-10.3010.3010.3010.3010.30
P/FCF Ratio
-3.0119.73-4.25-
PS Ratio
0.300.250.360.540.460.40